BioCorRx Inc. is an addiction treatment company offering a unique approach to the treatment of substance abuse addiction. The BioCorRx amp reg Recovery Program, a non addictive, medication assisted treatment MAT program, consists of two main components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers the non addictive medicine, naltrexone, an opioid antagonist that can significantly reduce physical cravings for alcohol and opioids. The second component of the program developed by BioCorRx Inc. is a one on one counseling program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long term naltrexone treatment. The Company also has an R amp amp D subsidiary, BioCorRx Pharmaceuticals, which is currently developing injectable and implantable naltrexone products for potential future regulatory approval. For more information on BICX, visit www.BioCorRx.com.
Quote | BioCorRx Inc. (OTCMKTS:BICX)
Last: | $0.49 |
---|---|
Change Percent: | 10.91% |
Open: | $0.49 |
Close: | $0.49 |
High: | $0.49 |
Low: | $0.49 |
Volume: | 400 |
Last Trade Date Time: | 07/08/2024 03:00:00 am |
News | BioCorRx Inc. (OTCMKTS:BICX)
ANAHEIM, CA - ( NewMediaWire ) - May 16, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the three months ended March 31, 2024, and...
2024-04-03 08:49:03 ET More on BioCorRx Financial information for BioCorRx Read the full article on Seeking Alpha For further details see: BioCorRx receives new patent for novel compound to treat pain, depression, and schizophrenia
Message Board Posts | BioCorRx Inc. (OTCMKTS:BICX)
Subject | By | Source | When |
---|---|---|---|
Ended up with way more buys than sells | Nathan123456 | investorshub | 12/13/2022 3:02:21 AM |
Someone must know something | JB51 | investorshub | 12/12/2022 8:36:48 PM |
I miss something? | Nathan123456 | investorshub | 12/12/2022 8:19:41 PM |
https://seekingalpha.com/news/3827831-biocorrx-starts-recruiting-in-trial-of-bio | 74 | investorshub | 05/06/2022 10:39:58 PM |
https://www.globenewswire.com/news-release/2022/02/14/2384416/0/en/BioCorRx-Anno | 74 | investorshub | 02/15/2022 1:53:42 AM |
News, Short Squeeze, Breakout and More Instantly...
ANAHEIM, CA - ( NewMediaWire ) - May 16, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the three months ended March 31, 2024, and...
ANAHEIM, CA - ( NewMediaWire ) - April 03, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer of innovative treatment programs for substance use and related disorders, today announced that its subsidiary BioCorRx Pharmaceuticals Inc., a clinical-stage biopharmace...
ANAHEIM, CA - ( NewMediaWire ) - April 02, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the year ended December 31, 2023, and reported on...